| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 12.372 | 649.340 | 761.873 | 611.398 | 956.828 | 1.532.026 | 1.155.688 |
| Total Income - EUR | - | - | - | 12.372 | 649.504 | 762.031 | 616.337 | 963.747 | 1.532.183 | 1.155.744 |
| Total Expenses - EUR | - | - | - | 11.549 | 461.885 | 566.913 | 466.660 | 712.005 | 1.128.038 | 916.967 |
| Gross Profit/Loss - EUR | - | - | - | 823 | 187.619 | 195.118 | 149.676 | 251.742 | 404.145 | 238.777 |
| Net Profit/Loss - EUR | - | - | - | 699 | 181.193 | 188.361 | 144.253 | 245.132 | 361.267 | 198.704 |
| Employees | - | - | - | 1 | 5 | 6 | 5 | 5 | 5 | 5 |
Check the financial reports for the company - Serramag Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 44 | 37.403 | 26.022 | 24.920 | 22.207 | 14.674 | 8.321 |
| Current Assets | - | - | - | 51.193 | 179.580 | 407.050 | 524.505 | 543.068 | 619.844 | 277.927 |
| Inventories | - | - | - | 37.602 | 59.929 | 59.817 | 54.772 | 40.389 | 67.049 | 70.378 |
| Receivables | - | - | - | 1.616 | 60.939 | 161.416 | 201.382 | 196.586 | 187.502 | 194.065 |
| Cash | - | - | - | 11.974 | 58.712 | 185.817 | 268.350 | 306.093 | 365.293 | 13.484 |
| Shareholders Funds | - | - | - | 742 | 181.921 | 279.816 | 366.706 | 509.092 | 620.550 | 200.597 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 50.494 | 35.777 | 153.928 | 183.608 | 58.714 | 34.167 | 108.084 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Serramag Med S.r.l.